Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from European Pharmaceutical Review

14:57 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "European Pharmaceutical Review" found in our extensive news archives from over 250 global news sources.

More Information about European Pharmaceutical Review on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about European Pharmaceutical Review for you to read. Along with our medical data and news we also list European Pharmaceutical Review Clinical Trials, which are updated daily. BioPortfolio also has a large database of European Pharmaceutical Review Companies for you to search.

Showing News Articles 1–25 of 434 from European Pharmaceutical Review

Wednesday 12th December 2018

Sprayable gel with CD47 blockers could be the future of drug delivery for cancer

A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer... The post Sprayable gel with CD47 blockers could be the future of drug delivery for cancer appeared first on

Tuesday 11th December 2018

Licences for manufacturers and wholesalers of medicines and ingredients

Updated public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended... The post Licences for manufacturers and wholesalers of medicines and ingredients appeared first on Eur

Tailored treatment for acute myeloid leukaemia

The screening of leukaemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for AML... The post Tailored treatment for acute myeloid leukaemia appeared first on European Pharmaceutical Review.

Monday 10th December 2018

Ocrelizumab reccommended for relapsing remitting multiple sclerosis

Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults. The post Ocrelizumab reccommended for relapsing remitting multiple sclerosis appeared first on European Pharmaceutical Review.

FDA grants frontotemporal dementia drug Orphan-Drug Designation

A dementia drug has been given Orphan Drug Designation by the FDA, meaning this special status will qualify sponsors of the drug for development incentives. The post FDA grants frontotemporal dementia drug Orphan-Drug Designation appeared first on

Friday 7th December 2018

Increasing dose of statins could save more lives

A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins... The post

Oxybutynin improves quality of life for breast cancer survivors

Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life... The post Oxybutynin improves quality of life for breast cancer survivors appeared first on European Pharmaceutic

‘Record year for pharma packaging and drug delivery innovation’ says Pharmapack

In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also accelerating across the drug delivery and packaging industries... The post ‘Record year for pharma packaging and drug delivery innovation’ says Phar

Thursday 6th December 2018

Five more countries to join EMA-FDA mutual recognition

The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)... The post Five more countries to join EMA-FDA mutual recognition appeared first on European Pharmaceutical Review.

CPhI report forecasts India to have strongest global growth in 2019

CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019... The post CPhI report forecasts India to have strongest global growth in 2019 appeared first on European Pharmaceutical Review.

PET tracer able to image tau in Alzheimer’s disease patients

Research into detecting tau proteins in the brains of Alzheimer's patients has shown that a specific tracer could detect and measure the protein levels... The post PET tracer able to image tau in Alzheimer’s disease patients appeared first on Eur

Wednesday 5th December 2018

Trastuzumab taken with carvedilol leads to less heart damage

A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients... The post Trastuzumab taken with carvedilol leads to less heart damage appeared first on

Tuesday 4th December 2018

Rivaroxaban reduced blood clots and related death in cancer patients

Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths... The post Rivaroxaban reduced blood clots and related death in cancer patients appea

Discovery to save more women in childbirth from postpartum hemorrhaging

The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year... The post Discovery to save more women in childbirth from postpartum hemorrhaging appeared first on

Monday 3rd December 2018

‘Elastic’ contrast protein for more accurate imaging

Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)... The post ‘Elastic’ contrast protein for more accurate imaging appeared first on European Pharmaceutical Review.

Global 2-year trial reports on CAR-T therapy to treat DLBCL

A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two year after the start... The post Global 2-year trial reports on CAR-T therapy to treat DLBCL appeared first on European Pharmaceutical Review.

Friday 30th November 2018

Cardiac cells integrated into microneedle patches could treat heart attacks

A tiny microneedle patch with could be the future of delivering stem cell related drugs to the heart of patients after a heart attack... The post Cardiac cells integrated into microneedle patches could treat heart attacks appeared first on

Metrohm USA contributes to global monograph modernisation initiative

Metrohm USA is proud to continue its productive collaboration with USP on a global initiative to modernise monographs that have traditionally featured wet chemistry methods... The post Metrohm USA contributes to global monograph modernisation initiative ap

Nanoscale blood test could discover more from cancer patients’ blood

A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages... The post Nanoscale blood test could discover more from cancer patients’ blood appeared first on European Pharmaceutical Review.

Thursday 29th November 2018

New brain circuits formed for motor function after Parkinson’s therapy

A gene therapy called AAV2-GAD has been associated with improved motor function, leading to researchers looking at its use in an upcoming Phase III trial... The post New brain circuits formed for motor function after Parkinson’s therapy appeared first on

Lanadelumab effective in reducing hereditary angioedema attacks

Results of a clinical trial has led to the FDA approval of a monoclonal antibody drug called lanadelumab, to treat hereditary angioedema attacks... The post Lanadelumab effective in reducing hereditary angioedema attacks appeared first on

Wednesday 28th November 2018

Pulsed radiofrequency could relieve sciatica and back pain

The use of pRF also could improve outcomes for patients set to receive corticosteroid injections, and was found to be minimally invasive with good results... The post Pulsed radiofrequency could relieve sciatica and back pain appeared first on European Pharmaceutical Review.

Canada clinical trial on personalised medicine for prostate cancer

A clinical trial could be the world's first to look at personalised medicine in prostate cancer, with patients taking a therapy based on their DNA markers... The post Canada clinical trial on personalised me

Tuesday 27th November 2018

Protection against yellow fever provided by fractional-dose vaccination

Researchers at Leiden University Medical Center have identified how fractional-dose yellow fever vaccinations protect against the condition for ten years... The post Protection against yellow fever provided by fractional-dose vaccination appeared first on European Pharmaceutical Review.

Using graphene as a tunable ion filter

NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems... The post Using graphene as a tunable ion filter appeared first on European Pharmaceutical Review.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks